• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于制备规模蛋白质生产的自动复性装置。

An automatic refolding apparatus for preparative-scale protein production.

机构信息

State Key Laboratory of Bioreactor Engineering, School of Biotechnology, East China University of Science and Technology, Shanghai, China.

出版信息

PLoS One. 2012;7(9):e45891. doi: 10.1371/journal.pone.0045891. Epub 2012 Sep 27.

DOI:10.1371/journal.pone.0045891
PMID:23029296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3459974/
Abstract

Protein refolding is an important process to recover active recombinant proteins from inclusion bodies. Refolding by simple dilution, dialysis and on-column refolding methods are the most common techniques reported in the literature. However, the refolding process is time-consuming and laborious due to the variability of the behavior of each protein and requires a great deal of trial-and-error to achieve success. Hence, there is a need for automation to make the whole process as convenient as possible. In this study, we invented an automatic apparatus that integrated three refolding techniques: varying dilution, dialysis and on-column refolding. We demonstrated the effectiveness of this technology by varying the flow rates of the dilution buffer into the denatured protein and testing different refolding methods. We carried out different refolding methods on this apparatus: a combination of dilution and dialysis for human stromal cell-derived factor 1 (SDF-1/CXCL12) and thioredoxin fused-human artemin protein (Trx-ARTN); dilution refolding for thioredoxin fused-human insulin-like growth factor I protein (Trx-IGF1) and enhanced fluorescent protein (EGFP); and on-column refolding for bovine serum albumin (BSA). The protein refolding processes of these five proteins were preliminarily optimized using the slowly descending denaturants (or additives) method. Using this strategy of decreasing denaturants concentration, the efficiency of protein refolding was found to produce higher quantities of native protein. The standard refolding apparatus configuration can support different operations for different applications; it is not limited to simple dilution, dialysis and on-column refolding techniques. Refolding by slowly decreasing denaturants concentration, followed by concentration or purification on-column, may be a useful strategy for rapid and efficient recovery of active proteins from inclusion bodies. An automatic refolding apparatus employing this flexible strategy may provide a powerful tool for preparative scale protein production.

摘要

蛋白质复性是从包涵体中回收有活性的重组蛋白的重要过程。通过简单稀释、透析和柱上复性方法进行复性是文献中报道的最常见技术。然而,由于每种蛋白质的行为变化多端,复性过程既耗时又费力,需要大量的反复试验才能成功。因此,需要自动化来使整个过程尽可能方便。在这项研究中,我们发明了一种自动装置,集成了三种复性技术:稀释、透析和柱上复性。我们通过改变变性蛋白中稀释缓冲液的流速并测试不同的复性方法来证明该技术的有效性。我们在该装置上进行了不同的复性方法:人基质细胞衍生因子 1(SDF-1/CXCL12)和硫氧还蛋白融合人 artemin 蛋白(Trx-ARTN)的稀释-透析组合;硫氧还蛋白融合人胰岛素样生长因子 I 蛋白(Trx-IGF1)和增强型荧光蛋白(EGFP)的稀释复性;牛血清白蛋白(BSA)的柱上复性。使用逐渐降低变性剂(或添加剂)的方法初步优化了这五种蛋白质的复性过程。使用这种降低变性剂浓度的策略,发现蛋白质复性的效率产生了更高数量的天然蛋白质。标准的复性装置配置可以支持不同应用的不同操作;它不仅限于简单的稀释、透析和柱上复性技术。通过逐渐降低变性剂浓度,然后在柱上进行浓缩或纯化进行复性可能是从包涵体中快速高效回收有活性蛋白质的一种有用策略。采用这种灵活策略的自动复性装置可为制备规模的蛋白质生产提供强大的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/504ab4f28987/pone.0045891.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/77053bb3e7e6/pone.0045891.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/889e6f61999c/pone.0045891.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/aba43dc72363/pone.0045891.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/b446180b4e58/pone.0045891.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/c0e6b3dcd8e3/pone.0045891.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/504ab4f28987/pone.0045891.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/77053bb3e7e6/pone.0045891.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/889e6f61999c/pone.0045891.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/aba43dc72363/pone.0045891.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/b446180b4e58/pone.0045891.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/c0e6b3dcd8e3/pone.0045891.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/3459974/504ab4f28987/pone.0045891.g006.jpg

相似文献

1
An automatic refolding apparatus for preparative-scale protein production.用于制备规模蛋白质生产的自动复性装置。
PLoS One. 2012;7(9):e45891. doi: 10.1371/journal.pone.0045891. Epub 2012 Sep 27.
2
Microfluidic chips with multi-junctions: an advanced tool in recovering proteins from inclusion bodies.具有多通道的微流控芯片:从包涵体中回收蛋白质的先进工具。
Bioengineered. 2015;6(1):1-4. doi: 10.4161/21655979.2014.987022. Epub 2015 Jan 7.
3
Refolding of recombinant human interferon alpha-2a from Escherichia coli by urea gradient size exclusion chromatography.通过尿素梯度尺寸排阻色谱法对源自大肠杆菌的重组人干扰素α-2a进行复性。
Prikl Biokhim Mikrobiol. 2013 Jan-Feb;49(1):17-23. doi: 10.7868/s0555109913010054.
4
Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies.从包涵体中回收具有生物活性的重组蛋白的复性技术。
Biomolecules. 2014 Feb 20;4(1):235-51. doi: 10.3390/biom4010235.
5
Controlled oxidative protein refolding using an ion-exchange column.使用离子交换柱进行可控氧化蛋白质重折叠
J Chromatogr A. 2005 Apr 1;1069(2):195-201. doi: 10.1016/j.chroma.2005.01.063.
6
Urea-gradient protein refolding in size exclusion chromatography.体积排阻色谱中的尿素梯度蛋白复性。
Curr Pharm Biotechnol. 2010 Apr;11(3):289-92. doi: 10.2174/138920110791112004.
7
A comparative investigation on different refolding strategies of recombinant human tissue-type plasminogen activator derivative.重组人组织型纤溶酶原激活剂衍生物不同复性策略的比较研究
Biotechnol Lett. 2006 Apr;28(7):457-63. doi: 10.1007/s10529-006-0001-z.
8
Modeling, simulation, and employing dilution-dialysis microfluidic chip (DDMC) for heightening proteins refolding efficiency.基于稀释透析微流控芯片(DDMC)的蛋白质复性效率提升的建模、模拟与应用。
Bioprocess Biosyst Eng. 2018 May;41(5):707-714. doi: 10.1007/s00449-018-1904-5. Epub 2018 Feb 22.
9
High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography.利用尿素梯度尺寸排阻色谱法从大肠杆菌中高效复性重折叠重组人粒细胞集落刺激因子。
Biotechnol Prog. 2008 Jan-Feb;24(1):209-13. doi: 10.1021/bp070263y. Epub 2008 Jan 8.
10
High hydrostatic pressure enables almost 100% refolding of recombinant human ciliary neurotrophic factor from inclusion bodies at high concentration.高静水压能够使高浓度包涵体中的重组人睫状神经营养因子几乎100%复性。
Protein Expr Purif. 2017 May;133:152-159. doi: 10.1016/j.pep.2017.03.014. Epub 2017 Mar 18.

引用本文的文献

1
Mechanistic Modeling of Size Exclusion Chromatography-Assisted Refolding of the Recombinant Biosimilar Teriparatide (PTH-34).尺寸排阻色谱辅助重组生物类似药特立帕肽(PTH-34)复性的机理模型
ACS Omega. 2024 Jan 5;9(3):3204-3216. doi: 10.1021/acsomega.3c04463. eCollection 2024 Jan 23.
2
Amelioration of DSS-Induced Acute Colitis in Mice by Recombinant Monomeric Human Interleukin-22.重组单体人白细胞介素-22改善小鼠DSS诱导的急性结肠炎
Immune Netw. 2022 Mar 30;22(3):e26. doi: 10.4110/in.2022.22.e26. eCollection 2022 Jun.
3
Cloning and codon optimization of a novel feline interferon omega gene for production by and its antiviral efficacy in polyethylene glycol-modified form.

本文引用的文献

1
Recombinant expression, purification and dimerization of the neurotrophic growth factor Artemin for in vitro and in vivo use.
Protein Expr Purif. 2012 Jan;81(1):25-32. doi: 10.1016/j.pep.2011.08.028. Epub 2011 Aug 31.
2
Exceptional stability of artemin neurotrophic factor dimers: effects of temperature, pH, buffer and storage conditions on protein integrity and activity.神经营养因子 artemin 二聚体的非凡稳定性:温度、pH 值、缓冲液和储存条件对蛋白质完整性和活性的影响。
Appl Biochem Biotechnol. 2011 Nov;165(5-6):1379-90. doi: 10.1007/s12010-011-9354-4. Epub 2011 Sep 3.
3
Highly efficient production of soluble proteins from insoluble inclusion bodies by a two-step-denaturing and refolding method.通过两步变性和复性方法从不溶性包涵体高效生产可溶性蛋白质。
克隆和密码子优化新型猫干扰素ω基因用于生产及其聚乙二醇修饰形式的抗病毒功效。
Virulence. 2022 Dec;13(1):297-309. doi: 10.1080/21505594.2022.2029330.
4
Cloning, Prokaryotic Soluble Expression, and Analysis of Antiviral Activity of Two Novel Feline IFN-ω Proteins.克隆、原核可溶性表达及两种新型猫干扰素-ω蛋白抗病毒活性分析。
Viruses. 2020 Mar 19;12(3):335. doi: 10.3390/v12030335.
5
The pilot-scale preparation of the SA-hGM-CSF bi-functional fusion protein.SA-hGM-CSF 双功能融合蛋白的中试规模制备。
Bioengineered. 2019 Dec;10(1):108-120. doi: 10.1080/21655979.2019.1608712.
6
Prospects on the Use of sp. to Develop Oral Vaccines.关于利用[具体物种名称]开发口服疫苗的前景。 (注:原文中“sp.”可能代表某个特定物种,这里按常规翻译方式处理,但需结合具体语境确定准确物种名)
Front Microbiol. 2018 Oct 25;9:2506. doi: 10.3389/fmicb.2018.02506. eCollection 2018.
PLoS One. 2011;6(7):e22981. doi: 10.1371/journal.pone.0022981. Epub 2011 Jul 29.
4
Refolding of proteins from inclusion bodies: rational design and recipes.包涵体中蛋白质的复性:合理设计与方案。
Appl Microbiol Biotechnol. 2011 Oct;92(2):241-51. doi: 10.1007/s00253-011-3513-y. Epub 2011 Aug 7.
5
Preparative Protein Production from Inclusion Bodies and Crystallization: A Seven-Week Biochemistry Sequence.从包涵体中制备蛋白质及结晶:一个为期七周的生物化学实验序列
J Chem Educ. 2011 Jul 1;88(7):986-989. doi: 10.1021/ed100594h.
6
Cellular strategies for controlling protein aggregation.控制蛋白质聚集的细胞策略。
Nat Rev Mol Cell Biol. 2010 Nov;11(11):777-88. doi: 10.1038/nrm2993. Epub 2010 Oct 14.
7
Step-wise refolding of recombinant proteins.分步复性重组蛋白。
Curr Pharm Biotechnol. 2010 Apr;11(3):285-8. doi: 10.2174/138920110791111979.
8
Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications.生物制药产品的过程分析技术 (PAT):第 I 部分。概念与应用。
Biotechnol Bioeng. 2010 Feb 1;105(2):276-84. doi: 10.1002/bit.22528.
9
Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12.心脏保护趋化因子SDF-1/CXCL12的单体结构
Protein Sci. 2009 Jul;18(7):1359-69. doi: 10.1002/pro.167.
10
Ultra scale-down of protein refold screening in microwells: challenges, solutions and application.微孔中蛋白质复性筛选的超微缩:挑战、解决方案及应用
Biotechnol Bioeng. 2009 Jun 1;103(2):329-40. doi: 10.1002/bit.22245.